MMP14 and colorectal carcinoma: Stage IV metastatic CRC tumors were grafted into NSG mice, and once tumors were established (approximately 100 mm3 in volume) animals were treated with either vehicle control or MMP14 inhibitor (NSC405020, 2.0 mg/kg/day) as illustrated in Figure 10A.